Skip to main content
OpenTrials

Clinical trial condition

Hypercholesterolemia

Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

719 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Hypercholesterolemia trial results

Completed

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT06005597

Conditions
ASCVD, Arterial Occlusive Diseases, Arteriosclerosis, +17 more
Locations
  • East Valley Diabetes & Endocrinology Gilbert, Arizona, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Progressive Medical Research Port Orange, Florida, United States
  • Centricity Research - Columbus Columbus, Georgia, United States
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

NCT04669041

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number :1560033 Baotou, China
  • Investigational Site Number :1560001 Beijing, China
  • Investigational Site Number :1560068 Beijing, China
  • Investigational Site Number :1560021 Beijing, China
View all 40 locations
View Trial Details
Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. / Simon Williamson Clinic, PC Birmingham, Alabama, United States
  • The Center for Clinical Trials, Inc Saraland, Alabama, United States
View all 181 locations
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details
Completed

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NCT05425745

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +14 more
Locations
  • Site 01022 Jonesboro, Arkansas, United States
  • Site 01015 Toluca Lake, California, United States
  • Site 01009 Sarasota, Florida, United States
  • Site 01023 Boise, Idaho, United States
View all 96 locations
View Trial Details

Related conditions